Disclosed positions

Estimated from their latest filings — positions may have changed since

$8.38M

combined est. value

Stock	Shares	Price	Value	Weight	As of
CDNACareDx, Inc.	165,060	$27.55	$4.55M	54%	2026-06-12
NTLAIntellia Therapeutics, Inc.	216,653	$16.84	$3.65M	44%	2026-06-09
KYTXKyverna Therapeutics, Inc.	21,727	$8.44	$183.4K	2%	2026-05-27

CDNA

CareDx, Inc.

$4.55M

165,060 sh

NTLA

Intellia Therapeutics, Inc.

$3.65M

216,653 sh

KYTX

Kyverna Therapeutics, Inc.

$183.4K

21,727 sh

Activity

Open-market buy & sell volume

BuySell

Total +$1.40M bought

Most bought

NTLA

$1.40M

All filings on record

Every Form 4 transaction we track for this filer

all 7buys 1sells 0

Stock	Transaction	Date	~6mo later
CDNACareDx, Inc.	Grant — · 9,795 sh	2026-06-12	—
NTLAIntellia Therapeutics, Inc.	Grant — · 9,200 sh	2026-06-09	—
KYTXKyverna Therapeutics, Inc.	Grant — · 5,093 sh	2026-05-27	—
NTLAIntellia Therapeutics, Inc.	Buy $1.40M · 150,000 sh	2026-01-05	+77.3%
CDNACareDx, Inc.	Grant — · 12,103 sh	2025-06-13	—
NTLAIntellia Therapeutics, Inc.	Grant — · 8,000 sh	2025-06-11	—
KYTXKyverna Therapeutics, Inc.	Grant — · 16,634 sh	2025-05-29	—

CDNAGrant

2026-06-12 · CareDx, Inc.

9,795

—

NTLAGrant

2026-06-09 · Intellia Therapeutics, Inc.

9,200

—

KYTXGrant

2026-05-27 · Kyverna Therapeutics, Inc.

5,093

—

NTLABuy

2026-01-05 · Intellia Therapeutics, Inc.

$1.40M

+77.3%

CDNAGrant

2025-06-13 · CareDx, Inc.

12,103

—

NTLAGrant

2025-06-11 · Intellia Therapeutics, Inc.

8,000

—

KYTXGrant

2025-05-29 · Kyverna Therapeutics, Inc.

16,634

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.